Stay updated with breaking news from Merck Sharp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mumbai, Baltimore, December 15, 2023: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration for...
Belzutifan (Welireg; Merck) demonstrated superior progression-free survival compared to everolimus in advanced renal cell carcinoma.
/PRNewswire/ -- Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. (NYSE: PFE) today announced that on December 15,...
Prophylactic HIV Drugs IndustryThe prophylactic HIV drugs industry size is projected to be worth US$32,516.1 million in 2023 and US$31,278.5 million in 2022.Growth in the market is primarily due to increased R&D investment in HIV clinical trials by pharmaceutical and biotechnology companies, increased HIV drug appr...
Clinical trial results show the immunogenicity, tolerability, and safety of V116 compared to a pneumococcal 20-valent conjugate vaccine for adults who had not previously received a pneumococcal vaccine.